Sundrug reports strong first half sales and profit growth

Sundrug Co., Ltd. announced its consolidated financial results for the first half of the fiscal year ending March 31, 2026, reporting a 5.8% increase in net sales to 418,437 million yen. Operating profit rose by 8.7% to 23,057 million yen, while ordinary profit increased by 9.9% to 22,893 million yen. Profit attributable to owners of parent grew 7.0% to 15,269 million yen. The company's total assets increased by 6,613 million yen to 450,620 million yen, and net assets rose by 7,744 million yen to 277,458 million yen, improving the equity ratio to 61.6%.

The strong performance was supported by the opening of 25 new stores and the renovation of 49 existing stores during the period. The total store count reached 1,553, comprising 1,127 drugstores and 426 discount stores. The drugstore segment's net sales increased by 4.5% to 267,028 million yen, with operating profit up 5.1% to 13,283 million yen. The discount store segment saw an 8.0% rise in net sales to 181,822 million yen and a 14.1% increase in operating profit to 9,774 million yen.

Sundrug maintains its full-year consolidated financial results forecast, anticipating net sales of 850,000 million yen, operating profit of 47,300 million yen, ordinary profit of 46,000 million yen, and profit attributable to owners of parent of 31,700 million yen. The company also projects a total annual dividend of 131.00 yen per share, with an interim dividend of 65.00 yen already declared and a year-end dividend of 66.00 yen expected.